Aspen Aerogels (ASPN) Liabilities and Shareholders Equity (2013 - 2026)

Aspen Aerogels has reported Liabilities and Shareholders Equity for 14 years, with the latest figure at $410.5 million in Q1 2026.

• For the quarter ending Q1 2026, Liabilities and Shareholders Equity fell 26.04% year-over-year to $410.5 million; the trailing twelve-month figure through Mar 2026 stood at $1.8 billion (down 38.49% YoY), and the FY2025 full-year result was $406.7 million, down 54.57% from the prior year.
• Liabilities and Shareholders Equity for Q1 2026 stood at $410.5 million, up from $406.7 million in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $895.1 million in Q4 2024, with the low at $341.0 million in Q1 2022.
• Historically, Liabilities and Shareholders Equity has averaged $575.6 million across 5 years, with a median of $605.1 million in 2023.
• Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity surged 251.68% — and 2025, when it plunged 54.57%.
• Aspen Aerogels' Liabilities and Shareholders Equity stood at $643.4 million in 2022, then increased by 9.27% to $703.0 million in 2023, then grew by 27.32% to $895.1 million in 2024, then sank by 54.57% to $406.7 million in 2025, then climbed by 0.93% to $410.5 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $410.5 million (Q1 2026), $406.7 million (Q4 2025), and $491.4 million (Q3 2025), per Business Quant data.